n

Glossary Terms

Syn-Ake

Also known as: Dipeptide Diaminobutyroyl Benzylamide Diacetate Synthetic analog of waglerin-1 (Temple Viper venom peptide). Postsynaptic nAChR antagonist targeting facial

Survodutide

Dual GLP-1R/GcgR agonist studied for weight loss and NASH. Phase II/III trials ongoing. 📖 Read the full Survodutide research overview

Substance P

Neuropeptide involved in neurogenic inflammation and follicle cycling. NK1 receptor antagonism—not supplementation—is the therapeutic rationale. Human biopsy data supports the

Substance P (Hair)

Neuropeptide involved in neurogenic inflammation and follicle cycling. NK1 receptor antagonism—not supplementation—is the therapeutic rationale. Human biopsy data supports the

SS-31 (Elamipretide)

Cardiolipin-targeting mitochondrial peptide. Phase III Barth syndrome trial (TAZPOWER) failed primary endpoint. Stealth BioTherapeutics dissolved. 📖 Read the full SS-31

SP/IGF-1 Ocular

SP/IGF-1 eye drops combine two small peptide fragments—FGLM-NH₂ from substance P and SSSR from IGF-1—that work together to heal the

Snap-8

Also known as: Acetyl Octapeptide-3 Extended SNARE complex inhibitor — argireline with two additional C-terminal residues. Greater in vitro binding

Setmelanotide

Also known as: Imcivree Setmelanotide is a daily injection that treats severe obesity caused by specific gene mutations. 📖 Read

Semax

Semax is a small peptide nasal spray made from a fragment of a stress hormone called ACTH—but with the stress

Scroll to Top